Abstract: A processing cartridge can be detachably installed in an electronic image forming device, where a protrusion capable of extending and retracting along a vertical direction is disposed inside the electronic image forming device. The processing cartridge includes a toner container and a waste toner container; and a movable element disposed at the lower side of the processing cartridge. The processing cartridge further includes a detachment preventing portion; the movable element is disposed with an abutting portion; and the abutting portion is capable of being abutted against the detachment preventing portion to prevent the movable element being disengaged. The processing cartridge further includes an elastic element; and the elastic element is configured to move the movable element toward the lower side of the processing cartridge.

Abstract: A method for identifying drug resistant genes and compositions containing agents that downregulate these genes in combination with a cancer therapeutic.

Abstract: A method for synchronous production of manganese tetraoxide and ferric oxide for a soft magnetic material by using marine polymetallic nodules includes: 1) crushing and grinding marine manganese nodules and baking to a constant weight; thoroughly mixing with a mixed flux and roasting in a muffle furnace; 2) carrying out solid-liquid separation, washing solid-phase precipitates with water, grinding the solid, adding sulfuric acid, controlling the temperature to be below 50° C., and vacuuming a reactor up; 3) adding a reducing agent to react at room temperature for 5-10 min, adding ammonia water to adjust the pH value to 5.5, and carrying out separation and filtering; 4) controlling the temperatures of manganese sulfate and ferric sulfate solutions to be below 50° C., and adding ammonium sulfide; and 5) washing with deionized water, and calcining at 800-900° C. for 1-3 s by a suspension low-temperature instantaneous firing system.

Abstract: A method for identifying drug resistant genes and compositions containing agents that downregulate these genes in combination with a cancer therapeutic.